|Venture Round, 10/2009 ||$500k|
|Venture Round, 1/2012 ||$4.55M|
|Venture Round, 10/2012 ||$325k|
|Venture Round, 12/2012 ||$250k|
|Venture Round, 6/2013 ||$1.25M|
|Venture Round, 2/2014 ||$326k|
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.
ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.